These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 25714595)
1. Ayahuasca Alters Structural Parameters of the Rat Aorta. Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595 [TBL] [Abstract][Full Text] [Related]
2. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015. Heise CW; Brooks DE J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660 [TBL] [Abstract][Full Text] [Related]
3. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052 [TBL] [Abstract][Full Text] [Related]
4. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Hamill J; Hallak J; Dursun SM; Baker G Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418 [TBL] [Abstract][Full Text] [Related]
5. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat. Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017 [TBL] [Abstract][Full Text] [Related]
6. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay. Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127 [TBL] [Abstract][Full Text] [Related]
9. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116 [TBL] [Abstract][Full Text] [Related]
10. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats. Favaro VM; Yonamine M; Soares JC; Oliveira MG PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991 [TBL] [Abstract][Full Text] [Related]
11. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158 [TBL] [Abstract][Full Text] [Related]
12. Biodiversity of β-Carboline Profile of Santos BWL; Oliveira RC; Sonsin-Oliveira J; Fagg CW; Barbosa JBF; Caldas ED Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32660098 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease. Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895 [TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. McKenna DJ; Towers GH; Abbott F J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171 [TBL] [Abstract][Full Text] [Related]
15. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant. Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968 [TBL] [Abstract][Full Text] [Related]
17. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context. Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972 [TBL] [Abstract][Full Text] [Related]
18. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312 [TBL] [Abstract][Full Text] [Related]
19. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography. Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026 [TBL] [Abstract][Full Text] [Related]
20. Ayahuasca for the Treatment of Depression. Palhano-Fontes F; Soares BL; Galvão-Coelho NL; Arcoverde E; Araujo DB Curr Top Behav Neurosci; 2022; 56():113-124. PubMed ID: 34761362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]